Antiplatelet and anticoagulant drugs do not affect visual acuity in the comparing bevacizumab to ranibizumab in age-related macular degeneration (BRAMD) trial

Author(s):
Schauwvlieghe, A.M.E.; Buitendijk, G.H.S.; Dijkman, G.; Hoyng, C.; Hooymans, J.M.; Verbraak, F.D.; Vingerling, J.R.; Claver, C.C.; Schlingemann, R.O.
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-04-30
Language
English
Is part of
Acta Ophthalmologica (2017), Vol. 95, p. 22-23
hdl
1887/116564